When will Numinus report earnings and what matters most

Numinus reports on 19 Jan 2026. For NUMI.TO stock investors, the key items are revenue recognition, clinic volumes, operating cash flow, and any guidance or licensing news that affects near-term revenue visibility.

What is Meyka AI's short-term price outlook for NUMI.TO stock

Meyka AI's forecast model projects **C$0.08** in 12 months for NUMI.TO stock, implying roughly **+60.00%** from the current **C$0.05**. Forecasts are model-based projections and not guarantees.

How liquid is NUMI.TO stock and what trading risks exist

NUMI.TO stock shows elevated pre-market volume **989,752** with avg volume **184,378**, but the low nominal price leads to wide spreads and execution risk. Use limit orders and smaller sizes to manage volatility.

What are the main valuation red flags for NUMI.TO stock

Numinus posts negative earnings (EPS **-0.08**) and distorted ratios such as price-to-book **-9.44**. The current ratio **0.61** and low cash per share **C$0.0028** are liquidity concerns that weigh on valuation.

CA Stocks

NUMI.TO Numinus Wellness (TSX) pre-market 16 Jan 2026: earnings could test liquidity

ByHuzaifa Zahoor January 16, 2026January 16, 2026

NUMI.TO stock trades at C$0.05 in pre-market activity on 16 Jan 2026 as investors position ahead of an earnings release scheduled for 19 Jan 2026. Volume is elevated at 989,752 shares versus an average of 184,378, highlighting short-term interest and thin liquidity. This earnings spotlight looks at valuation, cash metrics, and what the report must show to shift market sentiment before the TSX open.